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Neuroﬁbromatosis type 1 is a common autosomal dominant disorder caused by mutations of the NF1 gene on
chromosome 17. In only 5%–10% of cases, a microdeletion including the NF1 gene is found. We analyzed a set
of polymorphic dinucleotide-repeat markers ﬂanking the microdeletion on chromosome 17 in a group of seven
unrelated families with a de novo NF1 microdeletion. Six of seven microdeletions were of maternal origin. The
breakpoints of the microdeletions of maternal origin were localized in ﬂanking paralogous sequences, called “NF1-
REPs.” The single deletion of paternal origin was shorter, and no crossover occurred on the paternal chromosome
17 during transmission. Five of the six cases of maternal origin were informative, and all ﬁve showed a crossover,
between the ﬂanking markers, after maternal transmission. The observed crossovers ﬂanking the NF1 region suggest
that these NF1 microdeletions result from an unequal crossover in maternal meiosis I, mediated by a misalignment
of the ﬂanking NF1-REPs.
Neuroﬁbromatosis type I (NF1 [MIM 162200]) is a
common autosomal dominantly inherited disorder with
an incidence of ∼1/4,000 individuals (Huson et al.
1989). In 60%–70% of the patients, a truncating mu-
tation in the NF1 gene has been found (Heim et al.
1995). In 5%–10% of the cases, an NF1 gene micro-
deletion has been described, indicating that this type of
rearrangement must be present in ∼1/40,000 to ∼1/
80,000 individuals (Clementi et al. 1996; Cnossen et al.
1997; Rasmussen et al. 1998). So far, 65 patients car-
rying NF1 microdeletions have been reported in the lit-
erature (Kayes et al. 1994; Wu et al. 1995; Cnossen et
al. 1997; Valero et al. 1997; Upadhyaya et al. 1998;
Lo´pez-Correa et al. 1999a; Riva et al. 2000). Only a
few of those cases are familial (Leppig et al. 1997; Wu
et al. 1997). Most patients with NF1 microdeletions are
characterized by the presence of a more severe phenotype
with a variable facial dysmorphy (28/39 patients with
clinical description have coarse face, hypertelorism, pto-
sis, and/or a Noonan-like face), severe learning disabil-
ities or mild mental retardation, early and excessive de-
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velopment of cutaneous neuroﬁbromas, and, possibly, a
higher incidence of malignancies (Kayes et al. 1994; Wu
et al. 1995, 1999; Tonsgard et al. 1997).
In the majority of cases, the microdeletion (17q11.2)
is of maternal origin (Lazaro et al. 1996; Upadhyaya et
al. 1998). It is thought that the haploinsufﬁciency of the
NF1 gene, in combination with contiguous, genes may
be responsible for this particular phenotype (Leppig et
al. 1996).
Most of the NF1 microdeletions have a size of ∼1.5
Mb, and the deletion breakpoints cluster in a ﬂanking
duplicated region (NF1-REPs [Lo´pez-Correa et al.
1999a; Dorschner et al. 2000]). These so-called NF1-
REPs are paralogous regions of ∼100 kb (ﬁg. 1) in a
direct orientation, with ∼98% of homology (Dorschner
et al. 2000).
We genotyped seven families of patients with a de
novo NF1 deletion, to further analyze the molecular
mechanisms underlying these deletions. All patientswere
sporadic cases, and no NF1 manifestations were ob-
served in any of the parents. Each patient fulﬁlled the
NIH criteria for NF1. The patients were evaluated by
use of a standard protocol. Clinical features are de-
scribed in table 1. The presence and the approximate
size of the deletion are determined in all patients by use
of FISH probes and polymorphic microsatellites located
in the NF1-gene region (Lo´pez-Correa et al. 1999b).
Peripheral blood samples were obtained from patients
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Figure 1 Haplotype reconstruction of nine 17q11.2 markers in family 96-2 (paternal deletion) and family 98-1 (maternal deletion). The
hatched box indicates the markers included in the deleted region. The markers analyzed in the patients are, from top to bottom, D17S842,
D17S841, D17S1863, 5′NF1-1, IVS38, D17S1800, 3′NF1-4, D17S798, and D17S1880. Note a crossover between the two most telomeric
markers and the set of centromeric markers on the maternal chromosome 17 in the sibs of family 96-2.
with NF1 and from family members, after informed con-
sent was obtained. Grandparental blood samples were
collected according to the parental origin of the deletion
in six families, and blood from one unaffected sib was
collected in one family (96-2). We used six markers,
located in the sequences ﬂanking the common deletion
region, to elucidate the mechanism underlying the de-
letion; these markers were D17S842 (AFM240xe5),
D17S841 (AFM238vb10 ) , a nd D17S1863
(AFMc003ze1), mapping centromeric to the deletion re-
gion, and 3′NF1-4 (primer sequence and alleles of this
marker are available, by request, from the authors),
D17S1880 (AFMa072zh9 ) , a nd D17S798
(AFM179xg11), mapping telomeric to the common de-
leted region. The localization and genetic distances of
the markers are derived from resources at the National
Center for Biotechnology Information (NCBI), the
Whitehead Institute/MIT Center for Genome Research,
Mapping, and the Genome Database linkage maps.
Markers localized in the deleted region were IVS 38 (in
the NF1 gene), 5′NF1-1 (centromeric to the NF1 gene)
and D17S1800 (telomeric to the NF1 gene; ﬁg. 1). The
microsatellite markers were analyzed by PCR, as de-
scribed elsewhere (Lo´pez-Correa et al. 1999b). The re-
sults are represented in ﬁgures 1 and 2. All patients had
deletions conﬁrmed by FISH and microsatellite analysis.
Six patients had microdeletions of maternal origin, as
demonstrated by at least two intragenic markers, and
their deletion was ﬂanked by the NF1-REPs (ﬁg. 1). One
patient (family 96-2) had a shorter deletion of paternal
origin, which included only the NF1 gene and the three
genes embedded in intron 27b (EVI2A, EVI2B, and
OMGP [Lo´pez-Correa et al. 1999b]).
In the group of six patients with deletions of maternal
origin, a crossover between ﬂanking centromeric and
telomeric markers was observed in ﬁve informative
cases. In the sixth case, the markers were not informative
(X173). Thus, all ﬁve informative patients carrying a
maternally derived deletion showed a crossover between
markers ﬂanking the deletion region. In the patient car-
rying the smaller deletion of paternal origin, there is no
evidence of an interchromosomal recombination in the
deletion region on the paternal chromosome. Both sibs
inherited the same set of paternal markers ﬂanking the
deleted region (ﬁg. 1).
The genetic distance between markers D17S841/
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Table 1
Clinical Features in Patients with an NF1 Microdeletion
FEATURE
FAMILY
96-3 96 - 2a 96-1 97-1 98-1 99-1 X173
Age (years) 5 14 27 19 13 23 7
Sex F F F F M M F
Familial history       
Parental origin M P M M M M M
CLS       
Neuroﬁbromas       
Plexiform neuroﬁbroma    b c  
Macrocephaly       
Facial dysmorphism       
Madelung deformity       
Scoliosis       
Pectus excavatum/carinatum       
Overgrowth       
Learning difﬁculties NA      
Other Epilepsy;
unilateral
deafness
MPNST Hypertrichosis
NOTE.—Dysmorphic features observed in the reported patients are coarse face, hypertelorism, and
ptosis. Note that the oldest patient developed a malignant peripheral nerve-sheath tumor (MPNST) and
that two of the patients have a large plexiform neuroﬁbroma. NA = not ascertained. A minus sign ()
denotes presence, and a plus sign () denotes presence. No. of plus signs indicates level of severity.
a Patient with a paternal deletion.
b Facial.
c Leg.
D17S842 and D17S1880/D17S798 has been estimated
as ∼4 cM (NCBI, the Whitehead Institute/MIT Center
for Genome Research, and the Genome Database link-
age–radiation hybrids maps). The expected number of
meiotic recombinations in six individuals would be
∼0.24. The probability of detecting by chance ﬁve re-
combinations in six informative meioses is !5.8#
(binomial distribution; this assumes interference).710
This ﬁnding is highly suggestive of an unequal crossover
in maternal meiosis I, at the breakpoint of the deletion
and mediated by the NF1-REPs, as being the mechanism
leading to the deletion.
It has been observed that large DNA deletions re-
sulting in the loss of 1–5 Mb occur with a higher fre-
quency in speciﬁc regions of the human genome. The
breakpoints of those microdeletions appear to occur at
hot-spot regions. Low-copy repeats (REPs, duplicons, or
paralogous sequences) have been shown to ﬂank these
regions, facilitating the presence of homologous recom-
bination. It has been proposed that pericentromeric
regions are particularly prone to this kind of microde-
letion. Some of the microdeletion syndromes showing
ﬂanking repeats are Prader-Willi/Angelman syndromeon
chromosome 15q11.2 (Amos-Landgraf et al. 1999),
velo-cardio-facial syndrome and DiGeorge syndrome on
22q11 (Edelmann et al. 1999), Williams-Beuren syn-
drome on 7q11.2 (Perez Jurado et al. 1998), and he-
reditary neuropathy with liability to pressure palsies
(HNPP [Lopes et al. 1996]) and Smith-Magenis syn-
drome (SMS; Chen et al. 1997) on chromosome
17p11.2.
Different reports have been published recently con-
cerning the pathogenesis of these deletions, most spe-
ciﬁcally regarding the occurrence of inter- versus intra-
chromosomal rearrangements between the REPs.
Concerning the microdeletions located at 15q11.2,
22q11.2, and 7q11.2, no consistent sex-speciﬁc occur-
rence of inter- or intrachromosomal rearrangements
have been detected (Carrozzo et al. 1997; Baumer et al.
1998; Robinson et al. 1998).
The molecular rearrangement resulting in the deletion
(in the case of HNPP) and duplication (in the case of
Charcot-Marie-Tooth disease type A1) of the 1.5-Mb
region at 17p11.2 has been proposed to occur by two
different and sex-dependent mechanisms. Rearrange-
ments of paternal origin, which are mostly duplications,
are generated by interchromosomal recombination,
whereas deletions and duplications of maternal origin
result from an intrachromosomal rearrangement (Lopes
et al. 1997, 1998).
In contrast, in this study, the maternal NF1 deletions
occurred by an interchromosomal recombination in all
ﬁve informative cases, whereas the paternal deletion oc-
curred by a different mechanism. The observedmaternal
deletions probably occur bymisalignment of the ﬂanking
repetitive elements in homologous chromosomes at mei-
osis I (interchromosomal recombination). The paternal
deletion showed a different size and therefore was not
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Figure 2 Six markers located at the ﬂanking region of the deletion. The light-gray shadow indicates the large deletion region, of 1.5 Mb;
the dark-gray shadow indicates the shorter deletion, of ∼300 kb (only the NF1 gene), in 96-2. In patient X173, markers were not informative.
Note that four of ﬁve patients have the centromeric region of grandpaternal origin and the telomeric region of grandmaternal origin; in 97-1
the opposite phenomenon is found.
mediated by a recombination between the ﬂanking NF1-
REPs. This paternal deletion might have originated by
a different mechanism. Nevertheless, one patient with a
large paternal deletion of∼1.5Mb ﬂanked byNF1-REPS
has been described elsewhere (Dorschner et al 2000). It
is not known whether this large paternal microdeletion
is mediated by unequal crossover between NF1-REPs,
and it would be worthwhile to test this hypothesis.
The presence of an interchromosomal recombination
theoretically predicts the formation of a duplication
product on the other homologous chromosome involved
in the unequal crossover. Zygotes carrying such hypo-
thetical duplication are likely to be formed at the same
frequency as are zygotes with deletions. So far, no du-
plications involving the critical region 17q11.2 have
been described. Whether the duplication product is vi-
able and gives rise to a recognizable phenotype is still
unknown.
This reciprocal phenomenon has been described at the
17p11.2 region. Patients with SMS have a common con-
tiguous gene–deletion syndrome in 17p11.2 (Chen et al.
1997). Recently, a group of six patients with a mild
phenotype has been reported with duplications of the
SMS deletion region; those duplications are preferen-
tially of paternal origin and mostly arise from an inter-
chromosomal recombination event. The duplication is
probably the reciprocal recombination product of the
SMS deletion and represents a paradigm of the homol-
ogous recombination mechanism (Potocki et al. 2000).
In our study, six of seven microdeletions were of ma-
ternal origin, with apparently the same deletion size.
Five of these six arose by an unequal crossover, during
meiosis I, as a result of a homologous recombination
between NF1-REPs ﬂanking the deletion region. A sex-
dependent occurrence of interchromosomal rearrange-
ments in NF1 is hypothesized. A larger series of patients
is needed for conﬁrmation of this observation and in
order to study the mechanism in the much rarer micro-
deletions of paternal origin, especially those with the
common 1.5-Mb microdeletion region.
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